Basic Information
| LncRNA/CircRNA Name | GAS5-AS1 |
| Synonyms | NA |
| Region | GRCh38_1:173863248-173863941 |
| Ensemble | ENSG00000270084 |
| Refseq | NR_037605 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | m6A | Recurrence |
Cancer&Entry Information
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | qPCR, Luciferase reporter assay, in vitro knockdown, RIP, etc. |
| Sample | CC tissues, CC cell lines (Caski, SiHa, C33A and HeLa) and the normal cervical epithelium cell line (HCvEpC) |
| Expression Pattern | down-regulated |
| Function Description | The GAS5-AS1 expression in CC tissues was markedly decreased when compared with that in the adjacent normal tissues. The downregulation of GAS5-AS1 was significantly correlated with the advanced FIGO stage, distant metastasis, lymphatic metastasis and poor prognosis in patients with CC. Functionally, GAS5-AS1 drastically reduced CC cell proliferation, migration and invasion in vitro, and remarkably suppressed CC tumorigenicity and metastasis in vivo. Mechanistically, it was found that GAS5-AS1 interacted with the tumor suppressor GAS5, and increased its stability by interacting with RNA demethylase ALKBH5 and decreasing GAS5 N6-methyladenosine (m6A) modification. Moreover, it was shown that m6A-mediated GAS5 RNA degradation relied on the m6A reader protein YTHDF2-dependent pathway. |
| Pubmed ID | 31497208 |
| Year | 2019 |
| Title | Long noncoding RNA GAS5-AS1 suppresses growth and metastasis of cervical cancer by increasing GAS5 stability |
External Links
| Links for GAS5-AS1 | GenBank HGNC NONCODE |
| Links for cervical cancer | OMIM COSMIC |